J. Safra Sarasin Holding »

Alnylam Pharmaceuticals shares owned by J. Safra Sarasin Holding

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by J. Safra Sarasin Holding from 13F filings

Historical chart of J. Safra Sarasin Holding investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by J. Safra Sarasin Holding consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by J. Safra Sarasin Holding

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.1M 11k 275.03
2024-06-30 $1.7M 6.9k 243.00

More positions owned by J. Safra Sarasin Holding

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)
Merck & Co (MRK)
Ishares Core Msci Emkt (IEMG)
Apple (AAPL)
Cme (CME)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
International Business Machines (IBM)
Broadcom (AVGO)
Amgen (AMGN)
Colgate-Palmolive Company (CL)
Eli Lilly & Co. (LLY)

View all positions for J. Safra Sarasin Holding

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals